Mepartricin is an antifungal agent primarily used in veterinary medicine, particularly for the treatment of fungal infections in animals. It belongs to the class of compounds known as polyene macrolide antibiotics, which are characterized by their ability to bind to sterols in fungal cell membranes, leading to increased permeability and ultimately cell death. Mepartricin exhibits a broad spectrum of antifungal activity, particularly against dermatophytes and some yeasts. Its mechanism of action involves the disruption of membrane integrity, which is crucial for maintaining cellular function. The compound is typically administered topically or systemically, depending on the type of infection being treated. In terms of physical properties, Mepartricin is generally a white to off-white powder, and it is soluble in organic solvents but has limited solubility in water. Safety and efficacy profiles are well-documented in veterinary applications, although its use in humans is limited and not widely studied. As with any antifungal agent, resistance can develop, necessitating careful consideration of its use in treatment protocols.

Mepartricin

11121-32-7: Mepartricin is an antifungal agent primarily used in veterinary medicine, particularly for the treatment of fungal infections in animals. It belongs to the class of compounds known as polyene macrolide antibiotics, which are characterized by their ability to bind to sterols in fungal cell membranes, leading to increased permeability and ultimately cell death. Mepartricin exhibits a broad spectrum of antifungal activity, particularly against dermatophytes and some yeasts. Its mechanism of action involves the disruption of membrane integrity, which is crucial for maintaining cellular function. The compound is typically administered topically or systemically, depending on the type of infection being treated. In terms of physical properties, Mepartricin is generally a white to off-white powder, and it is soluble in organic solvents but has limited solubility in water. Safety and efficacy profiles are well-documented in veterinary applications, although its use in humans is limited and not widely studied. As with any antifungal agent, resistance can develop, necessitating careful consideration of its use in treatment protocols.

Mepartricin, a polyene macrolide, exhibits both antifungal and antiprotozoal activities and is extensively utilized in studies related to benign prostatic hyperplasia.

CAS 11121-32-7

Mepartricin

Mepartricin

Ref: TM-T201600

Mepartricin

Ref: 4Z-M-118001